TrialCancer chemotherapy and pharmacology2026

Pharmacologic de-escalation of dexamethasone during weekly paclitaxel: a randomized phase III trial evaluating safety, endocrine effects, and quality of life.

Vanessa Armenio Scontre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.